Lidds AB - Asset Resilience Ratio

Latest as of September 2025: 87.39%

Lidds AB (LIDDS) has an Asset Resilience Ratio of 87.39% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Lidds AB total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Skr1.73 Million

≈ $186.50K USD Cash + Short-term Investments

Total Assets

Skr1.98 Million

≈ $213.40K USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Lidds AB's Asset Resilience Ratio has changed over time. See LIDDS total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Lidds AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see LIDDS market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr1.73 Million	87.39%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr1.73 Million	87.39%

Asset Resilience Insights

Very High Liquidity: Lidds AB maintains exceptional liquid asset reserves at 87.39% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Lidds AB Industry Peers by Asset Resilience Ratio

Compare Lidds AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
Tubize-Fin BR:TUB	Biotechnology	0.05%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
Dashenlin Pharm Grp Co Ltd SHG:603233	Biotechnology	0.02%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	41.25%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.14%
Xiangxue Pharmaceutical SHE:300147	Biotechnology	0.05%

Annual Asset Resilience Ratio for Lidds AB (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Lidds AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	67.49%	Skr5.51 Million ≈ $592.53K	Skr8.16 Million ≈ $877.93K	-9.04pp
2023-12-31	76.53%	Skr13.51 Million ≈ $1.45 Million	Skr17.66 Million ≈ $1.90 Million	+56.25pp
2022-12-31	20.29%	Skr5.26 Million ≈ $565.84K	Skr25.92 Million ≈ $2.79 Million	-40.89pp
2021-12-31	61.18%	Skr34.00 Million ≈ $3.66 Million	Skr55.58 Million ≈ $5.98 Million	-5.37pp
2020-12-31	66.55%	Skr36.07 Million ≈ $3.88 Million	Skr54.20 Million ≈ $5.83 Million	+61.77pp
2019-12-31	4.78%	Skr7.56 Million ≈ $813.76K	Skr158.09 Million ≈ $17.01 Million	-11.22pp
2018-12-31	16.00%	Skr26.14 Million ≈ $2.81 Million	Skr163.38 Million ≈ $17.58 Million	+4.31pp
2017-12-31	11.69%	Skr15.29 Million ≈ $1.65 Million	Skr130.81 Million ≈ $14.08 Million	-3.75pp
2016-12-31	15.44%	Skr18.68 Million ≈ $2.01 Million	Skr121.01 Million ≈ $13.02 Million	--

pp = percentage points

About Lidds AB

ST:LIDDS Sweden Biotechnology

Market Cap

$361.27K

Skr3.36 Million SEK

Market Cap Rank

#30651 Global

#727 in Sweden

Share Price

Skr0.02

Change (1 day)

+0.00%

52-Week Range

Skr0.01 - Skr0.10

All Time High

Skr19.64